inhaled anticholinergic agent
Jump to navigation
Jump to search
Introduction
Includes:
Adverse effects
- increased cardiovascular risk (1.8 vs 1.2%)
- increased risk for arrhythmia in children & young adults[4]
- urinary retention, especially in men with BPH[3]
More general terms
More specific terms
References
- ↑ Singh S et al Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis JAMA 2008;300(12):1439-1450 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18812535
- ↑ Prescriber's Letter 15(11): 2008 Safety of Inhaled Anticholinergics for COPD Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=241102&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 3.0 3.1 Stephenson A et al Inhaled Anticholinergic Drug Therapy and the Risk of Acute Urinary Retention in Chronic Obstructive Pulmonary Disease. Arch Intern Med. 2011;171(10):914-920 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/21606096 <Internet> http://archinte.ama-assn.org/cgi/content/short/171/10/914
Singh S, Furberg CD. Inhaled anticholinergics for chronic obstructive pulmonary disease: Comment on "Inhaled Anticholinergic Drug Therapy and the Risk of Acute Urinary Retention in Chronic Obstructive Pulmonary Disease". Arch Intern Med 2011; 171(10):920-922 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21606097 - ↑ 4.0 4.1 Journal Watch: Physician's First Watch, May 23, 2012 Massachusetts Medical Society American Thoracic Society Meeting, May 18-23, 2012, San Francisco, CA
- ↑ Vande Griend JP, Linnebur SA. Inhaled anticholinergic agents and acute urinary retention in men with lower urinary tract symptoms or benign prostatic hyperplasia. Ann Pharmacother. 2012 Sep;46(9):1245-9. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/22851743